Czy bakteriofagi mogą być skutecznym i bezpiecznym lekiem na zakażenia spowodowane przez bakterie oporne na antybiotyki?

Aaronson X., Menglers B., 2017. The Virus That Kills Drug-Resistant Superbugs https://www.youtube.com/ watch?v=aVTOr7Nq2SM&t.

Abedon S. T., Thomas-Abedon C., 2010. Phage Therapy Pharmacology. Current Pharmaceutical Biotechnolog y, 11 (1), 28-47.

Ackerman H. W., Moineau S., Tremblay D., 2004. Long-term bacteriophage preservation. WFCC Newsletter 38, 35-40.

Ackerman H. W., 2011. Bacteriophage taxonomy. Microbilogy Australia, 90-94.

Adedeji W.A., 2016. The treasure called antibiotics. Annals of Ibadan Postgraduate Medicine, 14, (2), 56-57.

Bunting J., 1997. BBC Horizon: Phage - The Virus that Cres. https://archive.org/details/BBCHorizonS1997e13TheVirusThatCures.

Brown T. L., Petrovski S., Dyson Z. A., Seviour R., Tucci J., 2016. The Formulation of Bacteriophage in a Semi Solid Preparation for Control of Propionibacterium acnes Growth. PLOS ONE, 11, (3) https://doi.org/10.1371/journal.pone.0151184.

Brüssow H., Canchaya C., Hardt W. D., 2004. Phages and the Evolution of Bacterial Pathogens: from Genomic Rearrangements to Lysogenic Conversion. Microbiolog y and molecular biolog y reviews, 68, (3), 560-602.

Bruttin A., Brüssow H., 2005. Human Volunteers Receiving Escherichia coli Phage T4 Orally: a Safety Test of Phage Therapy. Antimicrobial Agents and Chemotherapy 49 (7), 2874–2878. DOI: 10.1128/AAC.49.7.2874-2878.2005.

Brzozowska E., Bazan J., Gamian A., 2011. Funkcje białek bakteriofagowych. Postępy Higieny i Medycyny Doświadczalnej 65, 167- 176. DOI: 10.5604/17322693.936090.

Canchaya C., Proux C., Fournous G., Bruttin A., Brüssow H., 2003. Prophage genomics. Microbiology and molecular biolog y reviews, 67, (2), 238-76.

Carlton R. M., 1999. Phage Therapy: Past History and Futre Prospects. Archivum Immunologiae et Therapiae Experimentalis, 47, 267– 274.

Chan B. K., Turner P. E., Kim S., Hamid R., Mojibian H. R., Elefteriades J. A., Narayan D., 2018. Phage treatment of an aortic graft infected with Pseudomonas aeruginosa. Evolution, Medicine, and Public Health, 2018 (1), 60–66. DOI: 10.1093/emph/eoy005.

Fischetti V. A., 2010. Bacteriophage endolysins: A nvel anti-infective to control Gram-positive pathogens. Int. J Med Microbiol 300(6), 357–362. DOI: 10.1016/j.ijmm.2010.04.002.

Jończyk E., Kłak M., Międzybrodzki R., Górski A., 2011. The influence of external factors on bacteriophages—review. Folia Microbiologica, 56 (3), 191-200. DOI: 10.1007/s12223-011-0039-8.

Keen E.C., 2015. A century of phage research: Bacteriophges and the shaping of modern biology. Bioessays, 37, (1), 6-9.

Lee Ligon B., 2004. Penicillin: its discovery and early development. Seminars in Pediatric Infectious Disease, 15 (1), 52-57.

Liu Y. Y., Wang Y., Walsh T. R., Yi L. X., Zhang R., Spencer J., Tian G., Dong B., Huang X., Yu L. F., Gu D., Ren H., Chen X., Ly L., He D., Zhou H., Liang Z., Liu J. H., 2015. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. The Lancet Infectious Diseases, 16 (2), 161-168. DOI: 10.1016/ S1473-3099(15)00424-7.

Loc-Carrillo C., Abedon S. T., 2011. Pros and cons of phage theraphy. Bacteriophage 1 (2), 111-114. DOI: 10.4161/bact.1.2.14590.

Mallmann W. L., Hemstreet C., 1924. Isolation of an inhibitory substance from plants. Journal of Agricultural Research, XXVIII, 6 Merabishvili M., Pirnay J. P., Verbeken G., Chanishvili N., Tediashvili M., Lashkhi N., Glonti T., Krylov V., Mast J., Van Parys L., Lavigne R., Volckaert G., Mattheus W., Verween G., De Corte P., Rose T., Jennes S., Zizi M., De Vos D., Vaneechoutte M., 2009. Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials. PLoS ONE, 4 (3), e4944. DOI: 10.1371/journal.pone.000494.

Navarro F., Muniesa M., 2017. Phages in the Human Body. Frontiers in microbiology, 8: 566, DOI: 10.3389/fmicb.2017.00566. eCollection 2017.

Sandeep K., 2006. Bacteriophage precision drug against bacterial infections. Current Science, 90, (5), 631-633.

Svircev A., Roach D., Castle A., 2018. Farming the Future with Bacteriophages in Agriculture. MDPI; Visruses 2018, 10, (5), 218 https://doi.org/10.3390/v10050218.

Van Boeckel T. P., Gandra S., Ashok A., Caudron Q., Grenfell B. T., Levin S. A., Laxminarayan R., 2014. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. The Lancet Infectious Diseases.;14(8), 742-750. DOI: 10.1016/ S1473-3099(14)70780-7.

Węgielska I., Suliburska J., 2016. Wpływ leków na mikroflorę jelitową. Forum Zaburzeń Metabolicznych, 7, (1), 1-7.

Woźnica W. M., Bigos J., Łobocka M. B., 2015. Lysis of bacterial cells in the process of bacteriophage release – canonical and newly discovered mechanisms. Postępy Higieny i Medycyny Doświadczalnej 69, 114-126. DOI: 10.5604/01.3001.0009.6484.